NASDAQ:RARX - Ra Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$20.05 -0.28 (-1.38 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$20.33
Today's Range$19.56 - $20.35
52-Week Range$4.78 - $23.90
Volume187,800 shs
Average Volume367,462 shs
Market Capitalization$649.58 million
P/E Ratio-8.32
Dividend YieldN/A
Beta0.9

Analyst Ratings

Ra Pharmaceuticals (NASDAQ:RARX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Ra Pharmaceuticals in the last 12 months. Their average twelve-month price target is $36.1667, suggesting that the stock has a possible upside of 80.38%. The high price target for RARX is $55.00 and the low price target for RARX is $25.00. There are currently 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.173.203.203.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $36.1667$32.40$23.00$19.60
Price Target Upside: 80.38% upside94.13% upside76.25% upside95.80% upside

Ra Pharmaceuticals (NASDAQ:RARX) Consensus Price Target History

Price Target History for Ra Pharmaceuticals (NASDAQ:RARX)

Ra Pharmaceuticals (NASDAQ:RARX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$55.00MediumView Rating Details
12/11/2018SunTrust BanksBoost Price TargetPositive ➝ Buy$35.00HighView Rating Details
12/10/2018BMO Capital MarketsSet Price TargetBuy$34.00HighView Rating Details
12/10/2018Jefferies Financial GroupBoost Price TargetPositive$40.00HighView Rating Details
10/19/2018Credit Suisse GroupSet Price TargetBuy$25.00LowView Rating Details
10/10/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$28.00HighView Rating Details
12/5/2017Royal Bank of CanadaReiterated RatingBuy$18.00HighView Rating Details
(Data available from 2/16/2017 forward)
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Featured Article: What is the yield curve?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel